Cargando…
Dendritic cell vaccines for high-grade gliomas
Glioblastoma (GBM) is the most common and fatal primary adult brain tumor. To date, various promising chemotherapeutic regimens have been trialed for use in GBM; however, temozolomide (TMZ) therapy remains the only US Food and Drug Administration-approved first-line chemotherapeutic option for newly...
Autores principales: | Eagles, Matthew E, Nassiri, Farshad, Badhiwala, Jetan H, Suppiah, Suganth, Almenawer, Saleh A, Zadeh, Gelareh, Aldape, Kenneth D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067774/ https://www.ncbi.nlm.nih.gov/pubmed/30100728 http://dx.doi.org/10.2147/TCRM.S135865 |
Ejemplares similares
-
How to live with a meningioma: experiences, symptoms, and challenges reported by patients
por: Nassiri, Farshad, et al.
Publicado: (2020) -
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020) -
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
por: Karimi, Shirin, et al.
Publicado: (2019) -
Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
por: Velásquez, Carlos, et al.
Publicado: (2019) -
Introduction: Ongoing clinical challenges in the management of meningiomas and future directions
por: Wang, Justin Z, et al.
Publicado: (2023)